Back
Genmab AS Vs. Belite Bio Industry Stock Comparison
Sell
30
GMAB
Genmab AS
Last Price:
21.16
Seasonality Move:
5.02%
Buy
89
BLTE
Belite Bio
Last Price:
67.60
Seasonality Move:
11.16%
Sell
30
Genmab AS (GMAB)
is a Sell
Is Genmab AS a Buy, Sell or Hold?
- The current Genmab AS [GMAB] share price is $20.65. The Score for GMAB is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- GMAB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
89
Belite Bio (BLTE)
is a Buy
Is Belite Bio a Buy, Sell or Hold?
- The current Belite Bio [BLTE] share price is $64.02. The Score for BLTE is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.
- BLTE is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
GMAB Stock Price Chart
BLTE Stock Price Chart
What is Belite Bio's stock price today?
-
The Belite Bio share price today is $64.02
The current trend is moderately bearish and BLTE is experiencing selling pressure, which indicates risk of future bearish movement.
GMAB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.77 | Sell |
| Relative Strength Index (14 RSI): | 30.68 | Sell |
| Chaikin Money Flow: | 281900 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.94 - 23.04) | Sell |
| Bollinger Bands (100): | (22.66 - 27.5) | Sell |
BLTE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.52 | Buy |
| Relative Strength Index (14 RSI): | 36.22 | Sell |
| Chaikin Money Flow: | -100485 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (67.51 - 82.53) | Sell |
| Bollinger Bands (100): | (44.23 - 67.87) | Buy |
GMAB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.6 | Buy |
| 20-day SMA: | 21.74 | Sell |
| 50-day SMA: | 22.93 | Sell |
| 200-day SMA: | 26.8 | Sell |
| 8-day EMA: | 20.84 | Sell |
| 20-day EMA: | 21.55 | Sell |
| 50-day EMA: | 22.92 | Sell |
| 200-day EMA: | 26.57 | Sell |
BLTE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 79.06 | Sell |
| 20-day SMA: | 76.97 | Sell |
| 50-day SMA: | 63.24 | Buy |
| 200-day SMA: | 49.93 | Buy |
| 8-day EMA: | 76.43 | Sell |
| 20-day EMA: | 75.29 | Sell |
| 50-day EMA: | 66.95 | Sell |
| 200-day EMA: | 52.3 | Buy |
Genmab AS Earnings Growth & GMAB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and an increase next year of $0.28 per share.
Belite Bio Earnings Growth & BLTE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.18 per share.
Genmab AS Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Belite Bio Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||